RE: RNS15 Dec 2021 09:55
"There is an increasing global demand for medical cannabis oils, and I believe the oils that will be most sought after will be those that have been validated in pre-clinical and clinical patent data that demonstrates successful results and not just random generic oils with no clinical testing. " stated Stephen D. Barnhill, MD, Chairman and CEO of Apollon Formularies, plc, "Our goal, as a Cannabis Licensing Authority (CLA) licensed processing facility, is to produce large amounts of the highest quality medicinal cannabis products with demonstrated successful clinical results for the medical patients in Jamaica and export for patients in other countries where legal import is allowed. This new high-volume processing laboratory will allow us to achieve that goal."
Dr. Herbert Fritsche, Apollon's Chief Science Officer, and Former Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at the University of Texas, MD Anderson Cancer Center in Houston, Texas stated, "In addition to significantly increasing our inventory for legal export, the high-volume processing laboratory also allows us to produce and store large volumes of our medical cannabis products for additional clinical trials to be performed by potential pharmaceutical partners, as may be required for legal approval in their jurisdictions. Having this increased inventory of analytically validated cannabis oil readily available, allows our potential partners to perform clinical trials in a reduced timeframe and have confidence in the consistency of product and the dose amounts established from those clinical trials."
Director of Research Development and Communications at the Cannabis Licensing Authority (CLA), Felicia Bailey, says the agency is committed to facilitating the import and export of cannabis until the import/export regulations are promulgated. Under the Interim Measures, licensees can export cannabis inflorescence/buds and extracts from Jamaica to jurisdictions across the world. CLA licensees have exported to countries such as Canada, Australia, Israel, Zimbabwe, and the Cayman Islands. "Getting into the global space is what we are aiming for, as becoming global players is very important, and that is why we are doing all that we can to ensure that our licensees have that ability to export and they have been taking advantage of that opportunity," said Ms. Bailey at a recent JIS Think Tank7
Jeff Nagel, Director of Processing and Product Manufacturing for Apollon, commented, "I want to congratulate our extraction team for their efforts in completing this new state-of-the-art processing laboratory and their dedication to producing the highest quality medical cannabis oils for our patients", Mr. Nagel continued, "The Jamaican landrace strains are giving us a very nice spectrum of not only THC and CBD but high levels of minor cannabinoids such as CBC, CBG and THCV for our medical cannabis formulations."
Sign In
Follow the stocks
